The involvement of the superoxide anion in endothelium-dependent relaxation (EDR) was examined in noradrenaline-contracted aortic smooth muscle preparations isolated from normotensive Wistar Kyoto rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). Acetylcholine (ACh, 10 -9 -10 -5 M) induced EDR in both WKY and SHRSP preparations in a concentration-dependent manner, but with a significantly smaller amplitude in those from SHRSP than in those from WKY. The ACh-induced EDR was inhibited by N ω -nitro-L-arginine (L-NOARG), in a concentration-dependent manner, both in WKY and SHRSP. The EDR produced in WKY in the presence of 3 × 10 -6 M L-NOARG was similar in magnitude to that produced in SHRSP in the absence of L-NOARG. Superoxide dismutase (SOD, 300 units/ml) increased the amplitude of EDR in SHRSP but not in WKY, with no alteration of the threshold or of the maximal amplitude. The maximal amplitude of EDR produced in SHRSP in the presence of SOD was still smaller than that in WKY. In WKY, a possible involvement of superoxide in the EDR was examined in aortae whose EDR was partially inhibited by treatment with a subthreshold concentration (3 × 10 -6 M) of L-NOARG. In the L-NOARG-conditioned aorta, the reduced EDR was partially but significantly recovered by SOD. These results suggest that the impaired EDR in aortae of SHRSP may be causally related to a higher production of superoxide. The L-NOARG-induced inhibition of EDR in WKY may be produced, in part, by the reduction of effective NO due to its destruction by superoxide.
Introduction
Endothelium-dependent relaxation (EDR) has been reported to be impaired in arteries of spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP), to an extent dependent on age and degree of hypertension (Hongo et al., 1988; Sunano et al., 1989; Tominaga et al., Correspondence to: Dr. Fumiko Sekiguchi, Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan Phone: +81-6-6721-2332 (ext. 3815) Fax: +81-6-6730-1394 e-mail: fumiko@phar.kindai.ac.jp 1994; Lang et al., 1995; Mantelli et al., 1995; Sunano et al., 2000) . The cause of the impairment varies between different arteries. For example, it has been shown to be due to the decreased release or response to endothelium-derived relaxing factor (EDRF) (Grunfeld et al., 1995; Hirata et al., 1996) , to increased release of endothelium-derived contracting factor (EDCF) (Lüscher and Vanhoutte, 1986; Watt and Thuston, 1989; Diederich et al., 1990) and to decreased endothelium-dependent hyperpolarization (Fujii et al., 1992 (Fujii et al., , 1993 Sunano et al., 1999) .
EDRF may be nitric oxide (NO) (Palmer et al., 1987) , and the production of NO from Larginine could be blocked by N ω -nitro-L-arginine (L-NOARG) (Moore et al., 1990) . Since EDRs of the aortae of both normotensive Wistar Kyoto rats (WKY) and SHRSP are largely inhibited by L-NOARG, it is considered that the EDRs are produced mainly by NO (Sekiguchi et al., 1996) . The reduction of EDR in SHRSP aortae may be the result of a decreased release of NO or a decreased response of smooth muscle to NO. However, the evidence from several studies indicates that a decreased release of NO is the more likely cause of the reduction, since the response of vascular smooth muscle to NO is not decreased in the aortae of SHRSP (Koga et al., 1989; Osugi et al., 1990; Tesfamariam and Ogletree, 1995) . NO is destroyed by the superoxide anion (Gryglewski et al., 1986; Palmer et al., 1987) , and superoxide is broken down by superoxide dismutase (SOD) (Gryglewski et al., 1986) . Thus it is possible that the reduced EDR of aorta in these hypertensive animals could be reversed by SOD. This is supported by the evidence that EDRs in the aortae of SHR and SHRSP are improved by SOD, possibly because it prevents the destruction of NO by superoxide (Nakazono et al., 1991; Grunfeld et al., 1995) . The present experiments were carried out to investigate a possible involvement of superoxide in the impairment of EDR in the aortae of SHRSP, and the results were compared with those obtained in aortae of WKY treated with L-NOARG.
Materials and Methods

Animals
Rats used in the present experiment were handled according to the "Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences" of the Physiological Society of Japan.
Male SHRSP and normotensive WKY were used in the present experiments. These rats were obtained from Shimizu Laboratory Supplies Co. Ltd. (Kyoto, Japan) at the age of 4 weeks and maintained in our animal facility until they were sacrificed. The rats were killed at the age of 16 weeks by bleeding from the anterior venae cavae during CO2 anesthesia. Aortae were removed from the thoracic cavity and immersed in a modified Tyrode's solution described below.
Solutions
The composition of the modified Tyrode's solution was (mM): NaCl, 137; KCl, 5.4; CaCl2, 2.0; MgCl2, 1.0; NaHCO3, 11.9; NaH2PO4, 0.4; glucose, 5.6; equilibrated with a gas mixture of 95% O2 and 5% CO2. The pH of the solution at 37°C was 7.3. High-K + Tyrode's solution containing 50 mM K + was made by substituting NaCl in the modified Tyrode's solution for equimolar KCl.
Preparations
Ring preparations of the aortae (1.0 mm in width) were made by cutting the aorta transversely with fine surgical scissors. In one tenth of the preparations, the endothelium was removed by rubbing the inner surface of the ring preparations gently with a soft rubber band. Two tungsten wires of 30 µm diameter were inserted into the lumen of each preparation and then one of them was tied to a plastic holder. This holder was mounted in an organ bath (10 ml) filled with modified Tyrode's solution kept at 37°C. The other wire was connected to a force transducer (Minebea, Nagano, Japan), so that changes in tension (contraction and relaxation) could be observed isometrically.
Mechanical recording
Preparations were equilibrated in modified Tyrode's solution for 60 min, then initially subjected to two successive high-K + -induced contractions of 30 min duration with an interval of 30 min, by changing the incubation medium from normal Tyrode's to high-K Tyrode's solution. After this procedure, the preparations were contracted by 5 × 10 -7 M noradrenaline (NA). Ten min after the preparation achieved contraction maximum, acetylcholine (ACh) was applied cumulatively to induce EDR. Superoxide dismutase (SOD) was applied 30 min before the initiation of the NA contraction and was present throughout both the NA-induced contraction and the ACh-induced relaxation. In the experiment where the relaxation was depressed by L-NOARG, SOD (3 × 10 -6 M or 10 -4 M) was added to the modified Tyrode's solution 30 min before the initiation of the NA-induced contraction and remained during throughout the contraction and the ACh-induced relaxation.
Drugs
Drugs used in the present experiment were noradrenaline bitartrate (Sigma, St. Louis, MO, USA), acetylcholine chloride (Wako Chem., Osaka, Japan), N ω -nitro-L-arginine (Sigma, St.
Louis, MO, USA) and bovine erythrocyte superoxide dismutase (SOD, Wako Chem., Osaka, Japan). Stock solutions of noradrenaline, acetylcholine, N ω -nitro-L-arginine and SOD were prepared by dissolving these chemicals into distilled water at concentrations of 0.1-10 mM or 30,000 unit/ml for SOD, and they were then added to Tyrode's solution to obtain the desired concentrations. The amount of solvent added in Tyrode's solution did not exceed 1/100 of the solution. The addition of these chemicals to Tyrode's solution did not alter the pH of the solution.
Statistics
Results are expressed as the mean ± S.E.M. with the number of observations in parenthesis. Relaxation responses are expressed as percentages of the NA-induced contraction. Differences between the preparations from WKY and SHRSP, between the values in the presence and absence of L-NOARG, and between the values in the absence and presence of SOD were analyzed using the unpaired Student's-t test, where a P value smaller than 0.05 was considered to be significant.
Results
Body weight and blood pressure of rats
The body weight and systolic blood pressure of WKY and SHRSP were measured just before sacrificing the animals. As shown in Fig. 1 , while the systolic blood pressure was markedly higher in SHRSP compared to WKY, the opposite was the case for body weight.
Endothelium-dependent relaxation of aortae from WKY and SHRSP
In aortic rings precontracted with noradrenaline (NA, 5 × 10 -7 M), acetylcholine (ACh) produced a relaxation response which was absent in tissues after removal of the endothelial cells by rubbing (i.e., endothelium-dependent relaxation, EDR). The amplitude of ACh-induced EDR increased in a concentration-dependent manner, both in SHRSP and WKY (Fig. 2) . For both WKY and SHRSP, the threshold concentration of ACh for the EDR was 10 -10 M, with the maximum response at 10 -6 M. The amplitude of the maximum relaxation was significantly (P<0.001) smaller in aortae from SHRSP (about 70% of NA contraction) than in those from WKY (about 90% of NA contraction).
Experiments were carried out to test the effects of L-NOARG on the ACh-induced EDR in aortae from WKY and SHRSP. As shown in Fig. 3 , the EDR was inhibited by N ω -nitro-L-arginine (L-NOARG, 3 × 10 -6
-10 -4 M) in a concentration-dependent manner, at any given concentrations of ACh, and EDR was abolished at 10 -4 M L-NOARG, both in WKY and SHRSP. In the presence of 3 × 10 -6 M L-NOARG, the EDR for aortae from WKY was identical to that for aortae from SHRSP in the absence of L-NOARG. These results confirmed the previous observation that in both WKY and SHRSP the ACh-induced EDR was produced mainly by endothelial NO (Sekiguchi et al., 1996) . 
Effects of superoxide dismutase on endothelium-dependent relaxation
The effects of superoxide dismutase (SOD) on EDR were studied in aortic rings obtained from WKY and SHRSP. SOD (300 units/ml) did not alter the NA-induced contractions. However in the presence of SOD, the ACh-induced EDR was significantly increased in SHRSP (Fig. 4B ) but no significant change was observed in WKY, at any given concentrations of ACh (Fig. 4A) . The threshold concentration of ACh required for generation of EDR (equal to 10 -10 M) was also not changed by SOD in both WKY and SHRSP.
Experiments were carried out to observe the effects of SOD on EDR in aortae of WKY which had been partially inhibited by L-NOARG. As shown in Fig. 3 , the ACh-induced EDR of WKY produced in the presence of 3 × 10 -6 M L-NOARG was identical to the EDR produced in SHRSP in the absence of L-NOARG. In the presence of 3 × 10 -6 M L-NOARG, the amplitude of EDR produced in aortae from WKY was again increased by 300 units/mil SOD (Fig. 5) . Although the amplitude of EDR produced by each concentration of ACh was smaller in L-NOARG-treated aortae from WKY than in those from SHRSP, the maximum amplitude of EDR produced by 10 -5 M ACh was 58.0 ± 7.2% (n=12) in the absence of SOD and 75.7 ± 4.1% (n=10) in the presence of SOD.
Discussion
Factors or mechanisms involved in EDR vary between different types of blood vessels (Shepherd and Katusic, 1991; Hwa et al., 1994; Zygmunt, et al., 1995; Shimokawa et al., 1996; Berman and Griffith, 1998; Tare et al., 2000) . The present results, that the ACh-induced EDR of both WKY and SHRSP aortae was blocked completely by removal of the endothelium or by application of 10 -4 M L-NOARG, indicate that the EDR is induced by endothelial NO (Sekiguchi et al., 1996) . It has been reported that NO is inactivated by superoxide, and thus superoxide may impaire EDR of vascular smooth muscle (Gryglewski et al., 1986; Rubanyi and Vanhoutte, 1986; Laight et al., 1998) . In the present experiments, the EDR of NA-contracted aortae was shown to be impaired in preparations from SHRSP, confirming a number of previously reported observations (Lüscher, 1988 , and also a review by Sunano et al., 2000) . Several mechanisms have been considered to be involved in the impairment of EDR in SHRSP, such as 1) reduced production of NO, 2) increased release of endothelium-derived relaxing factors such as endothelium-derived contractile factor (EDCF) and endothelium-derived hyperpolarizing factor (EDHF) or 3) diminished endothelium-dependent hyperpolarization of the smooth muscle membrane. Among these, the reduced release of NO may be the major mechanism for the reduction of EDR in aortae of SHRSP, since the EDR was mainly produced by the L-NOARG sensitive component. This agrees with previous reports that the release of NO is reduced in the aortic endothelium of SHRSP (Malinski et al., 1993; Hirata et al., 1996) .
A reduced NO-component of EDR in SHRSP may be produced either by a decreased release of NO from the endothelium or by the increased destruction of NO, since no significant difference in the relaxation of aortic smooth muscle to NO donors is observed between WKY and SHRSP (Sunano et al., 2000) . Increased destruction of NO may be produced by an interaction between NO and superoxide (Gryglewski et al., 1986; Palmer et al., 1987; Laight et al., 1998) . In fact, Grunfeld et al. (1995) observed that the release of NO decreased in the endothelial cells from SHRSP and the treatment of rats with SOD increased the release of NO. Pathogenesis of superoxide anion in the initiation of hypertension has also been reported in conventional SHR (Nakazono et al., 1991) . Thus, it is reasonable to consider that the increased release of superoxide anion may be one of the responsible mechanisms for the reduced release of NO in SHRSP. Scavenging superoxide by SOD may improve the impaired EDR by the destruction of NO in hypertensive rats. The present experiments confirmed that these were indeed the case in the aorta of SHRSP.
The present experiments showed that in WKY the reduced EDR with L-NOARG was partially recovered by treatment with SOD. The improved EDR by treatment with SOD has been reported in the rat aorta treated with a SOD inhibitor, diethyldithiocarbamate (Laight et al., 1998) and also in the L-NOARG-treated cerebral artery (Rosenblum et al., 1992) . These results suggest that the effects of SOD would be much more pronounced when production of NO is impaired. The present results showed that SOD showed no effect on EDR in aortae from WKY, and these agree with the report that the enhancing effect of SOD on the release of NO was less in the endothelial cells of WKY, although the release of NO even in the absence of SOD was higher than that of SHRSP in the presence of SOD (Grunfeld et al., 1995) . Thus, the present results confirm the functional alteration of aortic tissues in SHRSP, as was observed in the measurement of NO in endothelial cells of hypertensive animals.
The observation that the reduced EDR by L-NOARG was also restored by SOD could be interpreted by assuming the involvement of superoxide in the actions of L-NOARG. Inhibition by SOD of the actions of L-NOARG to EDR has been reported in cerebral arterioles (Rosenblum et al., 1992) . Since the enhancement by SOD of EDR in WKY was not observed in the absence of L-NOARG, it is unlikely that superoxide is basically inactivating NO in this preparation. In the partial inhibition by L-NOARG of the production of NO, scavenging superoxide by SOD may augment EDR. These results indicate a possible augmentation of the production of superoxide by L-NOARG or the drug itself may increase the synthesis of superoxide. It is reported that NO synthase (NOS) activates the generation of superoxide and that the actions are blocked by N ω -nitro-substituted L-arginine (Heinzel et al., 1992; Pou et al., 1992) . Taking these reports into consideration, such a possibility is unlikely. It is also reported that superoxide directly enhances the generation of NO (Hobbs et al., 1994) . An alternative explanation is that superoxide is synthesized in the aorta of WKY or as a result of stimulation by ACh, but that the amount of production is too little to alter the relaxation induced by endothelium-derived NO under control conditions, i.e., in the absence of L-NOARG. In the partial inhibition by L-NOARG of the production of NO, the amount of superoxide may be sufficient to impair the relaxation. It is suggested that the impairment of EDR in the aorta of SHRSP may be partly due to the reduction of effective NO due to its destruction by superoxide. Partial inhibition by L-NOARG of EDR produced in aortae from WKY may be caused, in part, by a mechanism similar to that found in SHRSP, i.e., the reduction of NO due to its destruction by superoxide.
